Company · CIK 1815974

# Anebulo Pharmaceuticals, Inc.

| CIK | [1815974](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001815974) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | ANEB (OTC) |
| First annual or quarterly report | 2021-06-21 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-268113 | Registered company Effective | 2022-11-02 | 2025-09-23 | 3 |
| 333-285098 | Shelf Effective | 2025-02-20 | 2025-09-23 | 4 |
| 333-254979 | IPO Final prospectus | 2021-04-01 | 2021-05-10 | 5 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-09-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1815974/999999999525003064/9999999995-25-003064-index.htm) Declared effective | 333-285098 | 9999999995-25-003064 |
| 2025-09-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1815974/999999999525003060/9999999995-25-003060-index.htm) Declared effective | 333-268113 | 9999999995-25-003060 |
| 2025-03-03 | [424B5](https://www.sec.gov/Archives/edgar/data/1815974/000149315225008861/0001493152-25-008861-index.htm) Shelf takedown | 333-285098 | 0001493152-25-008861 |
| 2025-02-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1815974/999999999525000562/9999999995-25-000562-index.htm) Declared effective | 333-285098 | 9999999995-25-000562 |
| 2025-02-20 | [S-3](https://www.sec.gov/Archives/edgar/data/1815974/000149315225007755/0001493152-25-007755-index.htm) Shelf registered | 333-285098 | 0001493152-25-007755 |
| 2022-11-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1815974/999999999522003277/9999999995-22-003277-index.htm) Declared effective | 333-268113 | 9999999995-22-003277 |
| 2022-11-02 | [S-1](https://www.sec.gov/Archives/edgar/data/1815974/000149315222030199/0001493152-22-030199-index.htm) Registration filed | 333-268113 | 0001493152-22-030199 |
| 2021-05-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1815974/000149315221010889/0001493152-21-010889-index.htm) Final prospectus | 333-254979 | 0001493152-21-010889 |
| 2021-05-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1815974/999999999521001821/9999999995-21-001821-index.htm) Declared effective | 333-254979 | 9999999995-21-001821 |
| 2021-05-05 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1815974/000149315221010495/0001493152-21-010495-index.htm) Amendment | 333-254979 | 0001493152-21-010495 |
| 2021-04-26 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1815974/000149315221009689/0001493152-21-009689-index.htm) Amendment | 333-254979 | 0001493152-21-009689 |
| 2021-04-01 | [S-1](https://www.sec.gov/Archives/edgar/data/1815974/000149315221007758/0001493152-21-007758-index.htm) Registration filed | 333-254979 | 0001493152-21-007758 |
| 2021-01-29 | [DRS](https://www.sec.gov/Archives/edgar/data/1815974/000149315221002099/0001493152-21-002099-index.htm) Draft made public | 377-04121 | 0001493152-21-002099 |

[All filings of this company](https://equitycapital.markets/filings?cik=1815974) · [CSV](https://equitycapital.markets/filings.csv?cik=1815974)

---
Source page: https://equitycapital.markets/company/1815974 · Data: U.S. SEC EDGAR · CC BY 4.0